Interviews with the world’s key opinion leaders in cancer

Tagmaintenance olaparib in ovarian cancer

First Line PARP Inhibition For Ovarian Cancer Assessed

November 2, 2018

Audio Journal of Oncology Podcast First Line PARP Inhibition For Ovarian Cancer Assessed Play Episode Pause Episode Mute/Unmute Episode Rewind 10...

November 1, 2018

Audio Journal of Oncology Podcast BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib Play Episode Pause Episode...